Avisi

Working on a nanotech defense against blindness from glaucoma. #VisiPlate 💫

[Avisi @avisi_tech]

Sharing strong 1-year safety and efficacy results from the #VITA trial of #VisiPlate aqueous shunt for open angle #glaucoma: https://t.co/omtTLg6U5x

[Avisi @avisi_tech]

June is Cataract Awareness Month. Cataracts is an eye disease that can cloud your vision, gradually diminishing the vibrancy of everyday moments. Share this message to help spread awareness and together we can help protect the gift of sight.

[Avisi @avisi_tech]

June is Cataract Awareness Month. Cataracts is an eye disease that can cloud your vision, gradually diminishing the vibrancy of everyday moments. Share this message to help spread awareness and together we can help protect the gift of sight.

[Avisi @avisi_tech]

Early detection and treatments could halt irreversible optic nerve damage and save your vision. Prioritize your health and book an eye exam this week!

[Avisi @avisi_tech]

As Healthy Vision Month comes to a close, it’s critical to raise awareness about glaucoma, the "silent thief of sight" that affects over 4 million in the US and over 100 million globally. A comprehensive dilated eye exam can detect glaucoma.

[Avisi @avisi_tech]

As Healthy Vision Month comes to a close, it’s critical to raise awareness about glaucoma, the "silent thief of sight" that affects over 4 million in the US and over 100 million globally. A comprehensive dilated eye exam can detect glaucoma.

[Avisi @avisi_tech]

If you or a family member has been diagnosed with Primary Open-Angle Glaucoma, then the SAPPHIRE Trial could be worth looking into. Visit https://t.co/WBFyVObkDx for more information and find a site near you!

[Avisi @avisi_tech]

If you or a family member has been diagnosed with Primary Open-Angle Glaucoma, then the SAPPHIRE Trial could be worth looking into. Visit https://t.co/WBFyVObkDx for more information and find a site near you!

[Avisi @avisi_tech]

Taking care of your eyes is important! Even if glaucoma doesn’t run in your family, scheduling a routine eye exam could help catch early signs of various health risks like glaucoma.

[Avisi @avisi_tech]

Taking care of your eyes is important! Even if glaucoma doesn’t run in your family, scheduling a routine eye exam could help catch early signs of various health risks like glaucoma.

[Avisi @avisi_tech]

It’s Healthy Vision Month! Schedule your routine eye exam today to support early detection and prevent future eye issues.

[Avisi @avisi_tech]

Learn more about VisiPlate Aqueous Shunt for Primary Open Angle Glaucoma and how to get involved in the SAPPHIRE Clinical Trial at https://t.co/WBFyVObkDx.

[Avisi @avisi_tech]

Congratulations to Dr. Shivani Kamat and the University of Texas Southwestern, Dallas team on their first VisiPlate implantation in the SAPPHIRE Clinical Trial!

[Avisi @avisi_tech]

"Its design suggests the capacity for significant IOP lowering while maintaining a straightforward, less invasive surgical approach - a combination that could make it a compelling option for a broad range of glaucoma patients"

[Avisi @avisi_tech]

"As a glaucoma surgeon, I found VisiPlate's procedure to feel both familiar and fluid. The material was novel, yet implantation came naturally and with ease. I believe this device has the potential to meaningfully advance how we approach glaucoma surgery..."

[Avisi @avisi_tech]

Congratulations to Dr. Shivani Kamat and the University of Texas Southwestern, Dallas team on their first VisiPlate implantation in the SAPPHIRE Clinical Trial!

[Avisi @avisi_tech]

At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, CO, Shaelynn Fisher presented Avisi’s hot topic poster “Characterization of a Novel Multichannel Glaucoma Shunt for Flow Resilience to Occlusions using Computational Fluid Dynamics.”

[Avisi @avisi_tech]

Thank you to the Association for Research in Vision and Ophthalmology (ARVO) for giving us the HOT TOPIC spot and opportunity to present. We enjoyed all the amazing connections made with others in our industry.

[Avisi @avisi_tech]

At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, CO, Shaelynn Fisher presented Avisi’s hot topic poster “Characterization of a Novel Multichannel Glaucoma Shunt for Flow Resilience to Occlusions using Computational Fluid Dynamics.”

[Avisi @avisi_tech]

Make sure to stop by and connect with Shaelynn Fisher and Sanjeev Kasthurirangan to learn more about the “Characterization of a Novel Multichannel Glaucoma Shunt for Flow Resilience to Occlusions using Computational Fluid Dynamics.”

[Avisi @avisi_tech]

Avisi’s poster was selected as a HOT TOPIC presentation for this year’s annual Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, Colorado. The poster presentation is on May 4th from 3:00 - 4:45 PM (posterboard #0808).

[Avisi @avisi_tech]

Avisi’s poster was selected as a HOT TOPIC presentation for this year’s annual Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, Colorado. The poster presentation is on May 4th from 3:00 - 4:45 PM (posterboard #0808).